<?xml version="1.0" encoding="UTF-8"?>
<p>According to previous studies, TMT-induced seizures are most significant on day 2 post-treatment, decreasing afterwards [
 <xref rid="B16-ijms-22-00679" ref-type="bibr">16</xref>,
 <xref rid="B17-ijms-22-00679" ref-type="bibr">17</xref>,
 <xref rid="B18-ijms-22-00679" ref-type="bibr">18</xref>]. Therefore, we compared TMT-induced seizures between groups on day 2 after TMT treatment (
 <xref ref-type="fig" rid="ijms-22-00679-f003">Figure 3</xref>a). TMT-injected mice presented systemic tremor and spasmodic gait (
 <xref ref-type="fig" rid="ijms-22-00679-f003">Figure 3</xref>b). However, PBWE + TMT-treated mice showed a significant decrease in seizure scores, mainly due to weak and systemic tremors, compared to the TMT-alone treated mice (
 <italic>n</italic> = 10 mice per group, * 
 <italic>p</italic> &lt; 0.05; 
 <xref ref-type="fig" rid="ijms-22-00679-f003">Figure 3</xref>b). Furthermore, while two mice died in the latter group, only one mouse died in the 5 mg/kg and none died in the 25 mg/kg PBWE + TMT groups (data not shown).
</p>
